Allstate (NYSE:ALL – Get Free Report) had its price objective lifted by research analysts at Keefe, Bruyette & Woods from $246.00 to $250.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the insurance provider’s stock. Keefe, Bruyette & Woods’ target price would indicate a potential upside of 20.83% from the stock’s current price.
ALL has been the subject of a number of other research reports. Wolfe Research upgraded shares of Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. BMO Capital Markets boosted their price target on shares of Allstate from $235.00 to $244.00 and gave the company an “outperform” rating in a report on Friday. Weiss Ratings restated a “buy (b)” rating on shares of Allstate in a research report on Wednesday, October 8th. Barclays reiterated an “underweight” rating and set a $198.00 target price (up from $188.00) on shares of Allstate in a report on Thursday, July 31st. Finally, Citigroup upgraded Allstate to a “hold” rating in a report on Wednesday, August 13th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $237.13.
Check Out Our Latest Analysis on ALL
Allstate Trading Up 1.5%
Allstate (NYSE:ALL – Get Free Report) last released its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share for the quarter, beating the consensus estimate of $5.48 by $5.69. The firm had revenue of $17.26 billion for the quarter, compared to analyst estimates of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The company’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.91 earnings per share. On average, equities research analysts anticipate that Allstate will post 18.74 EPS for the current year.
Institutional Trading of Allstate
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Atlas Capital Advisors Inc. lifted its stake in shares of Allstate by 197.3% in the first quarter. Atlas Capital Advisors Inc. now owns 6,712 shares of the insurance provider’s stock valued at $1,390,000 after buying an additional 4,454 shares in the last quarter. Commonwealth Retirement Investments LLC lifted its holdings in shares of Allstate by 103.5% in the second quarter. Commonwealth Retirement Investments LLC now owns 12,960 shares of the insurance provider’s stock valued at $2,609,000 after purchasing an additional 6,590 shares in the last quarter. Zurich Insurance Group Ltd FI bought a new stake in Allstate during the first quarter worth $22,405,000. Advisors Capital Management LLC purchased a new stake in Allstate in the 1st quarter valued at $301,000. Finally, Nordea Investment Management AB lifted its stake in Allstate by 434.3% during the 2nd quarter. Nordea Investment Management AB now owns 116,705 shares of the insurance provider’s stock valued at $23,115,000 after acquiring an additional 94,863 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Are Penny Stocks a Good Fit for Your Portfolio?
- Barrick’s Golden Quarter: Boosts Buyback and Dividend
- What is the NASDAQ Stock Exchange?
- Nebius Partners With Meta—AI Growth Could Send Stock to New Highs
- Are Penny Stocks a Good Fit for Your Portfolio?
- EVgo’s 37% Revenue Growth: Forget the Car, Buy the Gas Station
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
